| Grace Parraga | |
| Education: | BSc, MSc, Biochemistry, 1985, University of Western Ontario PhD, Biochemistry, 1991, University of Washington |
| Thesis Title: | Spectroscopic studies of mutant and wildtype zinc finger peptides: testing the zinc finger hypothesis. |
| Thesis Year: | 1991 |
| Workplaces: | Robarts Research Institute |
Grace–Eve Párraga (born 1961) is a Canadian lung-imaging scientist. She is a Tier 1 Canada Research Chair in Lung Imaging to Transform Outcomes at the University of Western Ontario.
Parraga was born in 1961.[1] She completed her Bachelor of Science and Master's degree in biochemistry from the University of Western Ontario (UWO) and her PhD at the University of Washington.[2]
Parraga was recruited to return to her alma mater in 2004 and subsequently joined the Robarts Research Institute.[3] In 2016, Parraga was named a UWO Faculty Scholar for her significant achievements in teaching or research.[4] Two years later, Parraga was appointed a Tier 1 Canada Research Chair in Lung Imaging to Transform Outcomes at UWO.[5]
During the COVID-19 pandemic, Parraga collaborated on a study to evaluate the long-term impacts of the virus. In July 2020, she co-initiated a study that used a 3.0 Tesla MRI scanner to evaluate patients’ lung structure and function at 12 weeks, six months, one year, and two years after the onset of infection.[3] Parraga also partnered with colleagues from Ryerson University, Lakehead University, McMaster University, and SickKids Hospital to use lung imaging technology to polarize and magnetize gas that patients inhale.[6] In September 2020, Parraga was elected a Fellow of the Canadian Academy of Health Sciences for her "pioneering research in advanced patient-based pulmonary imaging."[7]